Mutations in TOP2B cause autosomal-dominant hereditary hearing loss via inhibition of the PI3K-Akt signalling pathway
Mutations in TOP2B cause autosomal-dominant hereditary hearing loss via inhibition of the PI3K-Akt signalling pathway
复制标题
TOP2B 突变通过抑制 PI3K-Akt 信号通路导致常染色体显性遗传性听力损失
DOI:
10.1002/1873-3468.13482
复制
发表时间:
2019
期刊:
影响因子:
3.5
通讯作者:
Ma Zhaoxin
中科院分区:
文献类型:
--
作者:
Xia Wenjun;Hu Jiongjiong;Ma Jing;Huang Jianbo;Jing Tianrui;Deng Lisha;Zhang Jin;Jiang Nan;Ma Duan;Ma Zhaoxin
Hereditary hearing impairment is a clinically and genetically heterogeneous disease. Whole‐exome sequencing was performed on seven affected and six unaffected members in a large Chinese family with autosomal‐dominant nonsyndromic hearing loss. The pathogenic variant of the gene encoding human topoisomerase IIβTOP2B(c.G4837C:p.D1613H) was cosegregated with hearing loss in this pedigree and another two variants ofTOP2Bwere detected in 66 sporadic patients with hearing loss.top2bknockdown led to significant defects in zebrafish inner ears and caused downregulation ofaktwhich resulted in inactivation of PI3K‐Akt signalling. As a result, supporting cell and hair cell numbers were reduced through inhibition of the PI3K‐Akt pathway. Therefore, we hypothesized that mutations inTOP2Bcan cause autosomal‐dominant nonsyndromic hearing impairment through inhibition of the PI3K‐Akt signalling pathway.DatabaseThe whole‐exome sequence data in the study are available at the Sequence Read Archive database (NCBI) under the accession numbers SRR9050868, SRR9050867, SRR90508676, SRR90508675, SRR90508674, SRR90508673, SRR90508672, SRR90508671, SRR90508679, SRR90508670, SRR9050859. SRR9050858 and SRR9050857, respectively.